Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Rimonabant (SR141716) | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in body weight at 1 year. |
| Measure | Description | Time Frame |
|---|---|---|
| Metabolic parameters |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| ICD CSD | Sanofi | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinic of Physicians and Surgeons, LTD | Mesa | Arizona | 85201 | United States | ||
| Arizona Clinical Research Center, Inc. |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 16291982 | Result | Despres JP, Golay A, Sjostrom L; Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005 Nov 17;353(20):2121-34. doi: 10.1056/NEJMoa044537. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Tucson |
| Arizona |
| 85712 |
| United States |
| Irvine Center for Clinical Research (ICCR) | Irvine | California | 92618 | United States |
| Los Angeles Clinical Trials | Los Angeles | California | 90064 | United States |
| Apexute | Santa Ana | California | 92705 | United States |
| Clinical Research of South Florida | Coral Gables | Florida | 33134 | United States |
| Radiant Research | Stuart | Florida | 34996 | United States |
| nTouch Research | Peoria | Illinois | 61602 | United States |
| nTouch Research | South Bend | Indiana | 46601 | United States |
| Bluegrass Clinical Research, Inc. | Louisville | Kentucky | 40291 | United States |
| Johns Hopkins Women's Research Core | Lutherville | Maryland | 21093 | United States |
| Baystate Medical Center | Springfield | Massachusetts | 01199 | United States |
| Twin Cities Clinical Research | Arden Hills | Minnesota | 55126 | United States |
| Radiant Research | Edina | Minnesota | 55435 | United States |
| Women's Clinic of Lincoln, PC | Lincoln | Nebraska | 68510 | United States |
| New Mexico Clinical Research & Osteoporosis Center, Inc. | Albuquerque | New Mexico | 87106 | United States |
| Clinical Research Services | Bismarck | North Dakota | 58501 | United States |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | 45267-0559 | United States |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | United States |
| Clinical Research Division | Newtown | Pennsylvania | 18940 | United States |
| Clinical Research Center of Reading, LLC | West Reading | Pennsylvania | 19611-1124 | United States |
| Medical University of South Carolina, Division of Clinical Pharmacology | Charleston | South Carolina | 29425 | United States |
| Nashville Medical Research Institute | Nashville | Tennessee | 37205 | United States |
| Radiant Research | Salt Lake City | Utah | 84111 | United States |
| Clinical Research Center of Northern Virginia | Falls Church | Virginia | 22044 | United States |
| Hunter Holmes McGuire Medical Center Research Service (151) | Richmond | Virginia | 23249 | United States |
| Vancouver Medical Weight Loss Clinic | Vancouver | Washington | 98685 | United States |
| Addiction & Psychiatric Medicine Research | Morgantown | West Virginia | 26506-9300 | United States |
| Sanofi-aventis Administrative Office | Macquarie Park | Australia |
| Sanofi-aventis Administrative Office | Laval | Canada |
| Sanofi-aventis Administrative Office | Helsinki | Finland |
| Sanofi-aventis Administrative Office | Milan | Italy |
| Sanofi-aventis Administrative Office | Barcelona | Spain |
| Sanofi-aventis Administrative Office | Bromma | Sweden |
| Sanofi-aventis Administrative Office | Geneva | Switzerland |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050171 | Dyslipidemias |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000077285 | Rimonabant |
| ID | Term |
|---|---|
| D011720 | Pyrazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D010880 | Piperidines |
Not provided
Not provided